Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cytopathology ; 28(4): 273-279, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28217943

ABSTRACT

BACKGROUND: Fine needle cytology (FNC) of a parathyroid neoplasia (PN) is reliable, but needs to be confirmed by Parathormone (PTH) and Thyroglobulin (TG) immunoassay on needle washing or by immunocytochemistry (ICC) evaluation. The differentiation between parathyroid adenoma (PA), atypical adenoma (PAA) and carcinoma (PC) is difficult on histology or even impossible on FNC. The aim of this study was to evaluate possible cytological criteria to classify FNC-PN further. METHODS: Twenty-three FNC samples of PN and parathyroid cysts were rather then have been reviewed. The series includes 18 PNs, 4 cysts and 1 Thyr3B (histologically diagnosed as PA). Cytological features were: cellularity, patterns (follicular, solid or papillary), clear, oncocytic, isolated cells, nuclear atypia, cytoplasmic inclusions, nucleoli and mitoses. Data were compared with the histological controls. RESULTS: Seventeen PNs, 2 cysts and 1 Thyr3B FNC samples were histologically diagnosed as PA (16), PAA (2) and PC (2). Two cysts and 1 PN were not confirmed histologically. Cytological features and incidences were: high cellularity (1 PA, 1 PAA, 2 PCs), follicular (8 PAs, 1 PAA), solid (5 PAs, 1 PC), papillary pattern (1PA, 1 PAA, 1 PC), clear cells (4 PAs, 1 PAA, 2 PCs), oncocytic cells (6 PAs, 1 PAA, 2 PCs), isolated cells (5 PAs, 2 PAAs, 2 PCs), nuclear atypia (2 PAs, 1 PAA, 2 PCs), cytoplasmic inclusions (4 PAs, 2 PCs), nucleoli (2 PCs) and mitoses (2 PCs). CONCLUSION: Evident nucleoli and mitoses may suggest the differentiation between PA and PC. However, further investigations are required to confirm these preliminary observations.


Subject(s)
Parathyroid Glands/pathology , Parathyroid Neoplasms/diagnosis , Parathyroid Neoplasms/surgery , Biopsy, Fine-Needle , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Parathyroid Neoplasms/pathology
3.
Br J Cancer ; 93(4): 464-71, 2005 Aug 22.
Article in English | MEDLINE | ID: mdl-16106252

ABSTRACT

The hybridisation of an Affymetrix HG_U95Av2 oligonucleotide array with RNAs extracted from six human thyroid carcinoma cell lines and a normal human thyroid primary cell culture led us to the identification of the UbcH10 gene that was upregulated by 150-fold in all of the carcinoma cell lines in comparison to the primary culture cells of human normal thyroid origin. Immunohistochemical studies performed on paraffin-embedded tissue sections showed abundant UbcH10 levels in thyroid anaplastic carcinoma samples, whereas no detectable UbcH10 expression was observed in normal thyroid tissues, in adenomas and goiters. Papillary and follicular carcinomas were only weakly positive. These results were further confirmed by RT-PCR and Western blot analyses. The block of UbcH10 protein synthesis induced by RNA interference significantly reduced the growth rate of thyroid carcinoma cell lines. Taken together, these results would indicate that UbcH10 overexpression is involved in thyroid cell proliferation, and may represent a marker of thyroid anaplastic carcinomas.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma/genetics , Carcinoma/pathology , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology , Ubiquitin-Conjugating Enzymes/analysis , Animals , Biomarkers, Tumor/biosynthesis , Biomarkers, Tumor/genetics , Blotting, Western , Cell Proliferation , Cell Transformation, Neoplastic/genetics , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Mice , Mice, Transgenic , Rats , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , Ubiquitin-Conjugating Enzymes/biosynthesis , Ubiquitin-Conjugating Enzymes/genetics , Up-Regulation
5.
J Endocrinol ; 181(2): 263-70, 2004 May.
Article in English | MEDLINE | ID: mdl-15128274

ABSTRACT

Aurora/Ipl1-related kinases are a conserved family of proteins that have multiple functions during mitotic progression. High levels of Aurora kinases are characteristic of rapidly dividing cells and tumours. Aurora B encodes a protein that associates with condensing chromatin, concentrates at centromeres, and then relocates onto the central spindle at anaphase. In this study the expression and the localisation of Aurora B throughout germinal epithelial progression in normal testis and its neoplastic counterpart were analysed. Immunocytochemistry and RT-PCR analysis of mouse germinal epithelium cells showed the presence of Aurora B in spermatogonia and occasionally in spermatocytes. Western blot analysis revealed the typical Aurora B isoform ( approximately 41 kDa) in the same cellular types. A similar distribution was observed in human testis by immunohistochemistry. Moreover, the distribution and the expression of Aurora B were investigated in neoplasms derived from germ cells. Surgical samples of seminomas were analysed, and a high percentage of Aurora B positive cells (51%) was detected; the expression of Aurora B was significantly related to the MIB-1 proliferation marker (R=0.816). The data presented here demonstrate that Aurora B expression occurs in spermatogonial division. Furthermore, our results indicate that the expression of Aurora B is a consistent feature of human seminomas.


Subject(s)
Isoenzymes/analysis , Protein Serine-Threonine Kinases/analysis , Seminoma/enzymology , Spermatozoa/enzymology , Testicular Neoplasms/enzymology , Testis/enzymology , Animals , Aurora Kinase B , Aurora Kinases , Biomarkers/analysis , Cell Division , Immunohistochemistry/methods , Isoenzymes/genetics , Ki-67 Antigen/analysis , Male , Mice , Mice, Inbred Strains , Protein Serine-Threonine Kinases/genetics , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Spermatocytes/enzymology , Spermatogonia/enzymology
6.
J Clin Pathol ; 56(8): 587-91, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12890807

ABSTRACT

AIMS: Hashimoto's thyroiditis (HT) is an autoimmune disease in which both proliferation and apoptosis are enhanced. p27(Kip1) protein protects tissues from disease mechanisms that involve excessive cell proliferation and apoptosis. This study investigated whether there is loss of p27(Kip1) expression in HT and whether p27(Kip1) immunoreactivity has any relation to the proliferative indicator Ki-67. Because p27(Kip1) is regulated through either degradation, mediated by the S phase kinase associated protein 2 (Skp2), or sequestration, via D3 cyclin, the expression of these proteins was also investigated. METHODS: Immunohistochemistry was used to assess p27(Kip1), Ki-67, Skp2, and cyclin D3 expression in 19 cases of HT and in 10 normal thyroids. The results were evaluated by image analysis and reported as labelling indices (LIs) in both groups. RESULTS: The p27(Kip1) LI was lower in HT than in normal thyroid (28% v 75%; p < 0.001), whereas Ki-67 (1.13% v 0.13%), Skp2 (0.74% v 0.15%), and cyclin D3 (1.56% v 0.00%) LIs were higher in HT than in normal thyroids (p < 0.001). There was no correlation between p27(Kip1) and the expression of Ki-67, Skp2, and cyclin D3. CONCLUSIONS: p27(Kip1) downregulation is not exclusive to tumours but occurs also in HT, independently of the proliferative status and of changes in Skp2 and cyclin D3 expression. Further investigation is required to understand the mechanisms leading to p27 deregulation because these observations suggest that the regulation of p27(Kip1) expression in epithelial thyroid cells may play a role in HT pathogenesis.


Subject(s)
Cell Cycle Proteins/analysis , Image Processing, Computer-Assisted , Thyroid Gland/chemistry , Thyroiditis, Autoimmune/metabolism , Tumor Suppressor Proteins/analysis , Biomarkers/analysis , Case-Control Studies , Cell Nucleus/chemistry , Cyclin D3 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclins/analysis , Epithelial Cells/chemistry , Humans , Immunohistochemistry/methods , Ki-67 Antigen/analysis , Lymphocytes/chemistry , S-Phase Kinase-Associated Proteins , Thyroid Gland/immunology , Thyroiditis, Autoimmune/immunology
7.
Diagn Cytopathol ; 23(2): 77-81, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10888749

ABSTRACT

Recent studies on paraffin-embedded tissue have shown that the cyclin-dependent kinase inhibitor p27(Kip1) is expressed in normal thyroid cells, whereas it is downregulated in neoplastic cells. This prospective study was undertaken to assess whether p27(Kip1) staining may also be applied to fine-needle aspiration biopsy (FNAB) samples of the thyroid. We present here our preliminary results on 100 FNABs examined for p27(Kip1) expression. p27(Kip1) expression was assessed by immunocytochemistry; the technique was optimized on smears prepared from a normal thyreocyte cell line (TL5), which conspicuously expresses p27(Kip1), and then applied to FNAB samples prospectively collected from 80 cases of nodular goiter and 20 cases of thyroid neoplasms (10 papillary carcinomas and 10 follicular neoplasms). The TL5 cell culture smears showed that methanol fixation, followed by heat-induced antigen retrieval, is the most suitable technique for p27(Kip1) staining on cytological samples. The FNAB smears similarly treated showed high p27(Kip1) expression (75%) in goiter and a significantly lower expression (35%) in neoplasms (P < 0.0001). Our preliminary results show that: 1) p27(Kip1) protein expression can be reliably assessed on cytological samples; and 2) p27(Kip1) stains nonneoplastic and neoplastic samples in a different fashion, and thus is a useful tool in thyroid cytology.


Subject(s)
Cell Cycle Proteins , Enzyme Inhibitors/metabolism , Microtubule-Associated Proteins/metabolism , Thyroid Gland/metabolism , Tumor Suppressor Proteins , Adenocarcinoma, Follicular/diagnosis , Adenocarcinoma, Follicular/metabolism , Biopsy, Needle , Carcinoma, Papillary/diagnosis , Carcinoma, Papillary/metabolism , Cell Line , Cyclin-Dependent Kinase Inhibitor p27 , Fluorescent Antibody Technique, Indirect , Goiter, Nodular/diagnosis , Goiter, Nodular/metabolism , Humans , Prospective Studies , Thyroid Gland/pathology , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...